Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.185 USD | +8.82% | +20.40% | +24.77% |
Financials (USD)
Sales 2022 | 11.96M | Sales 2023 | 9.76M | Capitalization | 7.68M |
---|---|---|---|---|---|
Net income 2022 | -47M | Net income 2023 | -41M | EV / Sales 2022 | 4.65 x |
Net Debt 2022 | 29.37M | Net Debt 2023 | 30.62M | EV / Sales 2023 | 3.92 x |
P/E ratio 2022 |
-0.18
x | P/E ratio 2023 |
-0.08
x | Employees | 49 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.22% |
Latest transcript on Jaguar Health, Inc.
1 day | +0.06% | ||
1 week | -4.01% | ||
Current month | +89.10% | ||
1 month | +135.46% | ||
3 months | +47.83% | ||
6 months | -51.46% | ||
Current year | +12.29% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 19-04-30 |
Chief Tech/Sci/R&D Officer | 60 | 17-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
James Bochnowski
CHM | Chairman | 80 | 14-01-31 |
John Micek
BRD | Director/Board Member | 71 | 16-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.1876 | +10.35% | 16 313 260 |
24-04-25 | 0.17 | +0.06% | 20,038,575 |
24-04-24 | 0.1699 | +1.13% | 34,588,990 |
24-04-23 | 0.168 | -6.61% | 40,003,810 |
24-04-22 | 0.1799 | +14.66% | 106,875,256 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+12.29% | 46.96M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- JAGX Stock